These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34834587)

  • 1. Automated Assessment of the Substantia Nigra Pars Compacta in Parkinson's Disease: A Diffusion Tensor Imaging Study.
    Bergsland N; Pelizzari L; Laganá MM; Di Tella S; Rossetto F; Nemni R; Clerici M; Baglio F
    J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.
    Schwarz ST; Abaei M; Gontu V; Morgan PS; Bajaj N; Auer DP
    Neuroimage Clin; 2013; 3():481-8. PubMed ID: 24273730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach.
    Jokar M; Jin Z; Huang P; Wang Y; Zhang Y; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Min J; Liu F; Chen S; He N; Haacke EM; Yan F
    Neuroimage; 2023 Feb; 266():119814. PubMed ID: 36528314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential ultrastructural alterations in the Vglut2 glutamatergic input to the substantia nigra pars compacta/pars reticulata following nigrostriatal dopamine loss in a progressive mouse model of Parkinson's disease.
    Moore C; Xu M; Bohlen JK; Meshul CK
    Eur J Neurosci; 2021 Apr; 53(7):2061-2077. PubMed ID: 32619030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease.
    He N; Langley J; Huddleston DE; Chen S; Huang P; Ling H; Yan F; Hu X
    Neuroimage Clin; 2020; 28():102391. PubMed ID: 32889398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
    Atasoy HT; Nuyan O; Tunc T; Yorubulut M; Unal AE; Inan LE
    Neurol India; 2004 Sep; 52(3):332-7. PubMed ID: 15472421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean Apparent Propagator MRI Is Better Than Conventional Diffusion Tensor Imaging for the Evaluation of Parkinson's Disease: A Prospective Pilot Study.
    Le H; Zeng W; Zhang H; Li J; Wu X; Xie M; Yan X; Zhou M; Zhang H; Wang M; Hong G; Shen J
    Front Aging Neurosci; 2020; 12():563595. PubMed ID: 33192458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson's disease.
    Arribarat G; Pasternak O; De Barros A; Galitzky M; Rascol O; Péran P
    Parkinsonism Relat Disord; 2019 Aug; 65():146-152. PubMed ID: 31182373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
    Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
    Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered cerebral perfusion and microstructure in advanced Parkinson's disease and their associations with clinical features.
    Liu Z; Zhang Y; Wang H; Xu D; You H; Zuo Z; Feng F
    Neurol Res; 2022 Jan; 44(1):47-56. PubMed ID: 34313185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta.
    Langley J; Huddleston DE; Sedlacik J; Boelmans K; Hu XP
    Mov Disord; 2017 Mar; 32(3):441-449. PubMed ID: 28004859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease.
    He N; Ghassaban K; Huang P; Jokar M; Wang Y; Cheng Z; Jin Z; Li Y; Sethi SK; He Y; Chen Y; Gharabaghi S; Chen S; Yan F; Haacke EM
    Neuroimage; 2021 Apr; 230():117810. PubMed ID: 33524572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease.
    Kamagata K; Hatano T; Okuzumi A; Motoi Y; Abe O; Shimoji K; Kamiya K; Suzuki M; Hori M; Kumamaru KK; Hattori N; Aoki S
    Eur Radiol; 2016 Aug; 26(8):2567-77. PubMed ID: 26515546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion tensor imaging techniques show that parkin gene S/N167 polymorphism is responsible for extensive brain white matter damage in patients with Parkinson's disease.
    Yu J; Shi J; Chen L; Wang Y; Cai G; Chen X; Hong W; Ye Q
    Heliyon; 2023 Aug; 9(8):e18395. PubMed ID: 37600423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogenous response to aging of astrocytes in murine Substantia Nigra pars compacta and pars reticulata.
    Bondi H; Chiazza F; Masante I; Bortolotto V; Canonico PL; Grilli M
    Neurobiol Aging; 2023 Mar; 123():23-34. PubMed ID: 36630756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive MRI quantification of the substantia nigra pars compacta in Parkinson's disease.
    Takahashi H; Watanabe Y; Tanaka H; Mihara M; Mochizuki H; Takahashi K; Yamamoto K; Liu T; Wang Y; Tomiyama N
    Eur J Radiol; 2018 Dec; 109():48-56. PubMed ID: 30527311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Assessment of Diffusion Parameters and Cerebral Blood Flow Within Basal Ganglia in Early Parkinson's Disease.
    Pelizzari L; Laganà MM; Di Tella S; Rossetto F; Bergsland N; Nemni R; Clerici M; Baglio F
    Front Aging Neurosci; 2019; 11():134. PubMed ID: 31214017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PENCIL imaging: A novel approach for neuromelanin sensitive MRI in Parkinson's disease.
    Liu P; Wang X; Zhang Y; Huang P; Jin Z; Cheng Z; Chen Y; Xu Q; Ghassaban K; Liu Y; Chen S; He N; Yan F; Haacke EM
    Neuroimage; 2024 May; 291():120588. PubMed ID: 38537765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.
    Langley J; Huddleston DE; Merritt M; Chen X; McMurray R; Silver M; Factor SA; Hu X
    Hum Brain Mapp; 2016 Jul; 37(7):2547-56. PubMed ID: 27029026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.